GR862449B - 2-oxo-1-(((substituted sulfonyl) amino)-carbonyl)-azetidines - Google Patents

2-oxo-1-(((substituted sulfonyl) amino)-carbonyl)-azetidines

Info

Publication number
GR862449B
GR862449B GR862449A GR860102449A GR862449B GR 862449 B GR862449 B GR 862449B GR 862449 A GR862449 A GR 862449A GR 860102449 A GR860102449 A GR 860102449A GR 862449 B GR862449 B GR 862449B
Authority
GR
Greece
Prior art keywords
azetidines
oxo
carbonyl
amino
substituted sulfonyl
Prior art date
Application number
GR862449A
Other languages
Greek (el)
English (en)
Inventor
Breuer Hermann
Treuner D Uwe
Koster H William
Zahler Robert
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of GR862449B publication Critical patent/GR862449B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GR862449A 1985-09-26 1986-09-26 2-oxo-1-(((substituted sulfonyl) amino)-carbonyl)-azetidines GR862449B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78047985A 1985-09-26 1985-09-26

Publications (1)

Publication Number Publication Date
GR862449B true GR862449B (en) 1987-01-27

Family

ID=25119699

Family Applications (1)

Application Number Title Priority Date Filing Date
GR862449A GR862449B (en) 1985-09-26 1986-09-26 2-oxo-1-(((substituted sulfonyl) amino)-carbonyl)-azetidines

Country Status (31)

Country Link
JP (1) JPS6284082A (enExample)
KR (1) KR900001013B1 (enExample)
CN (1) CN86106980A (enExample)
AT (1) ATA257986A (enExample)
AU (1) AU600912B2 (enExample)
BE (1) BE905502A (enExample)
CA (1) CA1308719C (enExample)
CH (1) CH670828A5 (enExample)
DD (1) DD250121A5 (enExample)
DE (1) DE3632876A1 (enExample)
DK (1) DK460386A (enExample)
EG (1) EG18314A (enExample)
ES (1) ES2001995A6 (enExample)
FI (1) FI863890A7 (enExample)
FR (1) FR2587700B1 (enExample)
GB (1) GB2181130B (enExample)
GR (1) GR862449B (enExample)
HU (1) HU198044B (enExample)
IE (1) IE59686B1 (enExample)
IL (1) IL80160A (enExample)
IT (1) IT1214533B (enExample)
LU (1) LU86611A1 (enExample)
NL (1) NL8602446A (enExample)
NO (1) NO863837L (enExample)
NZ (1) NZ217704A (enExample)
PH (1) PH23315A (enExample)
PL (1) PL151546B1 (enExample)
PT (1) PT83440B (enExample)
SE (1) SE8604089L (enExample)
YU (1) YU46177B (enExample)
ZA (1) ZA867373B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502660A (ja) * 1986-05-23 1989-09-14 ジ・アップジョン・カンパニー N―1置換スルホニルアミノカルボニル、c―4置換モノバクタム類
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
KR890700588A (ko) * 1987-02-11 1989-04-25 로버어트 에이 아미테이지 항생 물질로서 신규 N-1 치환된 β -락탐
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0300636A1 (en) * 1987-07-22 1989-01-25 The Upjohn Company Therapeutically useful beta-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) * 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
US4871841A (en) * 1987-12-23 1989-10-03 E. R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
JPH01290674A (ja) * 1988-04-04 1989-11-22 E R Squibb & Sons Inc アゼチジニル誘導体
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
EP0604365B1 (en) * 1992-12-23 1999-05-26 Novartis AG Imidazole derivatives and their use as agrochemical agents
DE69405535T2 (de) * 1994-03-11 1998-04-02 Agfa Gevaert Nv Photographisches Material, das einen neuen Typ eines Hydrazides enthält
KR100596360B1 (ko) * 2003-07-15 2006-07-03 한국생명공학연구원 항암 활성을 갖는 신규 2-옥소-피페리딘 유도체(ⅰ)화합물을 포함하는 암 질환 치료를 위한 약학 조성물
US7511159B2 (en) * 2003-12-25 2009-03-31 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AU2012337781B2 (en) 2011-11-15 2017-07-06 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
CN106986820B (zh) * 2017-02-24 2019-05-21 浙江工商大学 多功能的羟基吡啶酮衍生物及其水合物的制备法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines

Also Published As

Publication number Publication date
NZ217704A (en) 1989-02-24
BE905502A (fr) 1987-01-16
FI863890A7 (fi) 1987-03-27
IE59686B1 (en) 1994-03-23
ES2001995A6 (es) 1988-07-01
IE862547L (en) 1987-03-26
GB8623151D0 (en) 1986-10-29
YU165986A (en) 1988-06-30
PT83440A (pt) 1986-10-01
IL80160A0 (en) 1986-12-31
FI863890A0 (fi) 1986-09-26
PL261575A1 (en) 1988-07-21
FR2587700B1 (fr) 1988-09-16
AU600912B2 (en) 1990-08-30
JPS6284082A (ja) 1987-04-17
PH23315A (en) 1989-07-14
LU86611A1 (fr) 1987-04-02
PL151546B1 (en) 1990-09-28
ZA867373B (en) 1987-05-27
AU6315686A (en) 1987-04-02
GB2181130A (en) 1987-04-15
IL80160A (en) 1991-04-15
IT1214533B (it) 1990-01-18
DK460386A (da) 1987-03-27
FR2587700A1 (fr) 1987-03-27
NL8602446A (nl) 1987-04-16
NO863837L (no) 1987-03-27
ATA257986A (de) 1994-07-15
HUT44535A (en) 1988-03-28
HU198044B (en) 1989-07-28
KR900001013B1 (ko) 1990-02-24
GB2181130B (en) 1989-09-20
NO863837D0 (no) 1986-09-26
EG18314A (en) 1993-02-28
YU46177B (sh) 1993-05-28
CN86106980A (zh) 1987-04-08
PT83440B (pt) 1989-05-12
SE8604089L (sv) 1987-03-27
KR870003101A (ko) 1987-04-15
CH670828A5 (enExample) 1989-07-14
DD250121A5 (de) 1987-09-30
SE8604089D0 (sv) 1986-09-26
DE3632876A1 (de) 1987-04-02
IT8621834A0 (it) 1986-09-26
CA1308719C (en) 1992-10-13
DK460386D0 (da) 1986-09-26

Similar Documents

Publication Publication Date Title
GR862449B (en) 2-oxo-1-(((substituted sulfonyl) amino)-carbonyl)-azetidines
AU569821B2 (en) Oxa-azahomocyclostatine polypeptides
GB8610551D0 (en) Polypeptide & protein derivatives
GB2199829B (en) Peptide derivatives
GB8602672D0 (en) Protein modification
ZW1486A1 (en) Peptide derivatives
AU2091988A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines
GB8702171D0 (en) Protein hydrolysates
DE3664715D1 (en) Improved protein hydrolysate
GB8817160D0 (en) Novel proteins
GB2207132B (en) 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
GB2182938B (en) Antihypertensive proline peptides
ZA895461B (en) Modified proteins
GB2206348B (en) 2-oxo-1(((substituted sulfonyl)amino)-carbonyl)azetidines
GB8500007D0 (en) Proteins
GB8725462D0 (en) Protein
AU2735888A (en) 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidiness
GB8725463D0 (en) Protein
GB9011637D0 (en) Peptide derivatives
CS821385A1 (en) Sposob cistenia 2 amino n (1 metyletyl)benzamidu
AU287934B2 (en) Polypeptides
IE862835L (en) Protein modification
AU4280564A (en) Polypeptides
MW486A1 (en) Peptide derivatives
GB8410528D0 (en) Immunosuppressive proteins